FDA-approved alternatives for tirzepatide weight loss For those concerned about the risks of compounded medications, FDA-approved options offer a path forward with more certainty about what you're getting
(April 2024)
June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026
For each of these treatments, it is recommended to schedule or anticipate 6-10 sessions for optimal results
This gives you access to all of the tools, recipes, and features of their app-based program
Clinicians look at your health history to ensure that a low-dose GLP-1 is a safe and effective choice for your body, especially if you have high sensitivity to medications or pre-existing conditions like reflux that might make higher doses difficult to tolerate